Senior insider sale
Sr VP, Drug Discovery at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$3.44M
163.97K shares
What this filing means
BENZENO SHARON plans to sell 163.97K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $3.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001950047-26-006622
Officer· Sr VP, Drug Discovery
Since Jun 2019
163.97K
Shares to sell
$3.44M
Approx. market value
152.93K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
6/29/2026
101.46KRestricted Stock Units
N/A
3/4/2026
51.47KTotal acquired152.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/29/2026 | Exercise of Stock Options Cash | 101.46K | — |
3/4/2026 | Restricted Stock Units N/A | 51.47K | — |
| Total | 152.93K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11.03K
Market value
$231.7K
6/26/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
152.93K
Market value
$3.21M
6/29/2026
Total
Units
163.97K
Value
$3.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2026 | 11.03K | $231.7K | — | Completed |
| Planned — Approximate Date | ||||
6/29/2026 | 152.93K | $3.21M | NASDAQ | Planned |
| Total | 163.97K | $3.44M | ||